PV QMS for Market Entry Case Study

Building a PV System for Market Entry

How PVCON helped a biotech company establish the pharmacovigilance structure, documentation and governance needed to support launch.

The Product Was Moving Toward Launch. The PV System Was Not Yet Ready.

A biotech company preparing for market entry had reached a critical stage in its launch programme.

The commercial and regulatory pathway was progressing, but the pharmacovigilance infrastructure required to support post-market responsibilities was still incomplete.

Core SOPs had not yet been fully established. Roles and governance needed definition. PSMF documentation required development, and supporting controls around training, agreements, deviations and CAPAs were not yet operating as one connected system.

The challenge was therefore larger than producing a set of documents.

The company needed a working PV Quality Management System that could support day-to-day operations, define accountability and provide evidence that pharmacovigilance responsibilities were under control before launch.

Building the PV Foundation Around How the Company Would Operate

PVCON developed the pharmacovigilance QMS as an integrated operating framework rather than as a collection of standalone documents.

The engagement covered the development and implementation of SOPs, governance structures, PSMF documentation, training materials, safety agreements, deviation management and CAPA processes.

Roles and responsibilities were defined so that key PV activities had clear ownership.

The documentation framework was then connected to the processes required to maintain it, including PV training and upskilling, controlled-document management and issue follow-up.

As implementation progressed, identified gaps were tracked and closed so that the organisation could move toward market entry with both the documentation and the operating controls required to support the PV system.

What Had to Be in Place Before Launch

PV System Area	What Was Needed	PVCON Support	Evidence of Readiness
QMS Documentation	Controlled PV procedures	SOP and controlled-document development	40 controlled documents implemented
Governance	Defined roles and responsibilities	PV governance framework	Clearer ownership across PV activities
PSMF	Core system documentation	PSMF development and alignment	PSMF structure established
Training	Staff readiness	Role-based PV training	18 employees trained
Quality Controls	Deviations, CAPAs and identified gaps	Tracking and remediation support	16 gaps closed

From Missing Infrastructure to an Operating PV System

Within 14 weeks, the company implemented 40 controlled documents, trained 18 employees, and closed 16 identified gaps.

The work gave the organisation a more complete and structured pharmacovigilance foundation ahead of market entry.

The outcome was not limited to documentation readiness. The company had clearer governance, trained personnel, defined PV processes and a more organised framework for managing deviations and CAPAs.

Following implementation, zero major PV findings were reported.

Built for Launch, Structured for What Comes After

A PV system created for market entry has to do more than satisfy a launch checklist.

It must continue to support responsibilities once the product is on the market.

For this biotech company, the engagement created a more structured foundation for operating, maintaining and demonstrating pharmacovigilance control beyond the immediate launch period.

Preparing for market entry? Explore PVCON's PV QMS consulting support or contact PVCON to discuss building a PV system ready to operate from day one.